Cover Image

Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease

Background. The study of drug availability for patients with chronic obstructive pulmonary disease (COPD) represents one of the priority tasks in the organization of effective counteraction to COPD in the Russian Federation.Objective: to assess drug prices, affordability, and availability for COPD p...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. A. Orlova (Author), V. I. Petrov (Author), I. P. Dorfman (Author), O. V. Shatalova (Author), M. A. Orlov (Author)
Format:	Book
Published:	IRBIS LLC, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correlation analysis between inflammatory biomarkers and significant clinical phenotypes of chronic obstructive pulmonary disease
by: Ekaterina A. Orlova, et al.
Published: (2023)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015)

PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015)

ECONOMIC DAMAGE OF PNEUMOCOCCAL VACCINATION ABSENCE AS A RISK FACTOR FOR COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. A. Orlova, et al.
Published: (2022)

ЕSTIMATION OF SOCIO-ECONOMIC BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE FOR A 5-YEAR PERIOD: A REGIONAL ASPECT
by: E. A. Orlova, et al.
Published: (2021)

Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future
by: John O'Reilly
Published: (2015)

Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease
by: Bo-Guen Kim, et al.
Published: (2022)

Influence of Mechanical Ventilation Modes on the Efficacy of Nebulized Bronchodilators in the Treatment of Intubated Adult Patients with Obstructive Pulmonary Disease
by: Cibelle Andrade Lima, et al.
Published: (2023)

PHARMACOECONOMIC EVALUATION OF ANTI-PNEUMOCOCCAL VACCINATION IN RISK GROUPS FOR THE PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA AMONG ADULTS IN THE ASTRAKHAN REGION
by: E. A. Orlova, et al.
Published: (2021)

Features of the clinical course of chronic pancreatitis in patients with chronic obstructive pulmonary disease
by: O. S. Khukhlina, et al.
Published: (2024)

Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: V. I. Petrov, et al.
Published: (2019)

Serum Vitamin A and Inflammatory Markers in Individuals with and without Chronic Obstructive Pulmonary Disease
by: L. M. O. Caram, et al.
Published: (2015)

Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study
by: Jun-Jun Yeh, et al.
Published: (2019)

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease
by: Melissa H. Roberts, et al.
Published: (2019)

EARLY DETECTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - VECTOR ON BIOMARKERS
by: V. I. Shevcova, et al.
Published: (2016)

One stone two birds: anti-inflammatory bronchodilators as a potential pharmacological strategy for COVID-19
by: Yuanyuan Yu, et al.
Published: (2023)

Experimental study of chronic toxicity and anti-inflammatory properties of the drug Dilept
by: S. V. Alekseeva, et al.
Published: (2016)

Exercise-Induced Laryngeal Obstruction: When Pediatric Exertional Dyspnea Does not Respond to Bronchodilators
by: J. Tod Olin
Published: (2019)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2017)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2016)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2017)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015)

Comorbidity in chronic obstructive pulmonary disease patient
by: Leonid I. Dvoretsky
Published: (2023)

Correction of therapy of concerned cardiovascular disease and chronic obstructive pulmonary disease in a patient with pulmonary tuberculosis
by: Natalia V. Bagisheva, et al.
Published: (2021)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015)

ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS
by: T. V. Adasheva, et al.
Published: (2016)

THE CASE OF PULMONARY EMBOLISM IN A PATIENT WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Karnaushkina, et al.
Published: (2016)

EVALUATION OF VENTILATION-PERFUSION RATIO IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: T.A. MIROSHKINA, et al.
Published: (2021)

Therapy correction of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report
by: Natalia V. Bagisheva, et al.
Published: (2022)

Longitudinal Assessment of Pulmonary Function and Bronchodilator Response in Pediatric Patients With Post-infectious Bronchiolitis Obliterans
by: Xiuhua Yu, et al.
Published: (2021)

Patterns of bronchodilator therapy in asthmatic outpatients
by: Toetik Aryani, et al.
Published: (2023)

Influence of chronic obstructive pulmonary disease on health status of the population of Ukraine
by: V. Mikhalchuk, et al.
Published: (2017)

Influence of chronic obstructive pulmonary disease on health status of the population of Ukraine
by: V. Mikhalchuk, et al.
Published: (2017)

Analysis the cost of chronic obstructive pulmonary disease in Russian Federation
by: I. S. Krysanov
Published: (2018)

Anti-inflammatory effect of Gyeji-tang in a chronic obstructive pulmonary disease mouse model induced by cigarette smoke and lipopolysaccharide
by: Eun Bok Baek, et al.
Published: (2022)

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
by: E. A. Shelest, et al.
Published: (2015)

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
by: E. A. Shelest, et al.
Published: (2015)